In Brief: SmithKline Beecham's Bactroban
Executive Summary
SmithKline Beecham's Bactroban: Approved Sept. 18 as a "2S," indicating a new salt of a currently marketed drug given standard review. Bactroban (calcium mupirocin) ointment is indicated for the eradication of nasal carriage of Staphylococcus aureus, including methicillin-resistant strains...